This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Malignant neoplasm of gum, excluding all cancers (controls excluding all cancers)
C3_GUM_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
329 |
4. Check minimum number of eventsNone |
329 |
5. Include endpointsNone |
329 |
6. Filter based on genotype QC (FinnGen only) |
329 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of gum, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of oral cavity, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 329 | 162 | 167 |
| Unadjusted period prevalence (%) | 0.06 | 0.06 | 0.07 |
| Median age at first event (years) | 67.12 | 68.02 | 66.24 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 124
- Matched controls
- 1238
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C03.1
ICD-10 Finland
Malignant neoplasm: Lower gum
+∞
113.7
91
*
130
Kela drug reimbursment
Malignant tumour
+∞
85.6
72
*
8070/3-C03.1
ICD-O-3
Squamous cell carcinoma, NOS, of lower gum
+∞
76.1
65
*
EDB00
NOMESCO Finland
Partial excision of mandible
+∞
74.7
64
*
ECA20
NOMESCO Finland
Biopsy of gingiva
358.1
72.8
67
*
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
+∞
57.9
51
*
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
304.1
56.1
53
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
27.2
54.2
103
189
JDB10
NOMESCO Finland
Percutaneous gastrostomy
275.4
52.4
50
*
GBB00
NOMESCO Finland
Tracheostomy
275.4
52.4
50
*
C03.0
ICD-10 Finland
Malignant neoplasm: Upper gum
+∞
50.5
45
*
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
373.4
50.0
47
*
SAA03
NOMESCO Finland
Extended examination of mouth
26.5
49.4
109
266
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
+∞
46.9
42
*
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
21.4
45.5
76
85
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
44.5
40
*
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
99.4
42.6
45
7
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
281.0
40.4
39
*
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
+∞
37.4
34
*
EKA10
NOMESCO Finland
Biopsy of cheek
86.7
34.3
37
6
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
31.3
33.7
45
22
K13.79
ICD-10 Finland
Change in the oral mucosa UNS
44.5
32.9
40
13
SBB10
NOMESCO Finland
Teeth copy
26.4
32.0
45
26
EBB10
NOMESCO Finland
Insertion of dental implant
92.5
31.8
34
5
WX408
NOMESCO Finland
General anesthesy, balanced
11.0
31.5
76
156
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
30.0
30.4
41
20
8070/3-C03.0
ICD-O-3
Squamous cell carcinoma, NOS, of upper Gum
+∞
29.3
27
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
63.5
29.2
33
7
A03FA01
ATC
metoclopramide; systemic, rectal
13.0
29.0
57
76
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
11.0
28.9
65
113
EJA10
NOMESCO Finland
Biopsy of tongue or floor of mouth
44.2
27.2
33
10
ZZQ20
NOMESCO Finland
Free microvascular graft of skin, muscle and bone
+∞
25.9
24
*
ZXE30
NOMESCO Finland
More than five and less than seven hours
26.5
25.3
35
18
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
71.5
25.3
28
5
EBB15
NOMESCO Finland
Insertion of dental implant abutment
108.7
24.7
26
*
WX110
NOMESCO Finland
Local anesthesy
13.5
24.7
114
568
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
294.6
24.6
24
*
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
68.2
24.2
27
5
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
7.5
23.8
90
322
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
+∞
23.7
22
*
H02AB02
ATC
dexamethasone; systemic
56.9
23.5
27
6
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
22.6
21
*
EBA15
NOMESCO Finland
Extraction of large number of teeth
19.1
21.4
33
23
XX3DW
NOMESCO Finland
Time consuming IT work
20.1
21.2
32
21
A07AA02
ATC
nystatin; oral
13.6
21.1
38
39
EEB00
NOMESCO Finland
Partial excision of maxilla
+∞
20.4
19
*
WF002
NOMESCO Finland
Radical radiotherapy
+∞
20.4
19
*
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
125.2
20.2
21
*
SAA04
NOMESCO Finland
Special inverstigation of mouth
16.2
19.5
32
26
EP1AE
NOMESCO Finland
Neck ultrasound examination
14.2
19.5
34
32
C02.11
ICD-10 Finland
Malignant neoplasm of border of tongue
+∞
19.3
18
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
19.3
18
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
27.0
19.1
26
12
N02AA05
ATC
oxycodone; systemic
8.0
18.6
47
88
K13.29
ICD-10 Finland
Indefinite leukoplakia
111.2
18.1
19
*
EHA10
NOMESCO Finland
Biopsy of palate
208.6
18.0
18
*
R4190
NOMESCO Finland
Nutritional therapy
37.7
17.7
22
7
ZXE40
NOMESCO Finland
More than seven and less than nine hours
37.7
17.7
22
7
SBA00
NOMESCO Finland
Microbiological examinations
33.0
17.2
22
8
K13.78
ICD-10 Finland
Other change in the oral mucosa
27.8
17.2
23
10
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prothetic work
14.8
17.2
29
25
EBB11
NOMESCO Finland
Insertion of additional dental implant in one session
+∞
17.1
16
*
A04AA02
ATC
granisetron; systemic, transdermal
+∞
17.1
16
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
17.1
16
*
SPA20
NOMESCO Finland
Selection and insertion of implantdistans
195.2
16.9
17
*
ZXE90
NOMESCO Finland
More than 22 hours
69.5
16.2
18
*
SXC03
NOMESCO Finland
Other oral or dental procedure
69.5
16.2
18
*
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
+∞
16.0
15
*
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
+∞
16.0
15
*
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
+∞
16.0
15
*
R4110
NOMESCO Finland
Physiotherapy
5.4
15.8
60
184
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
52.1
15.5
18
*
XF612
NOMESCO Finland
Measurement of central venous pressure
+∞
14.9
14
*
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
169.1
14.8
15
*
WZC30
NOMESCO Finland
Teaching
7.8
14.7
36
62
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
18.8
14.6
22
14
WX404
NOMESCO Finland
Intravenous generell anesthesy
6.0
14.5
45
107
ZXE60
NOMESCO Finland
More than 12 and less than 15 hours
60.7
14.2
16
*
SPF20
NOMESCO Finland
Temporary soling for filling
84.3
13.9
15
*
JN4BD
NOMESCO Finland
Extensive body CT
11.4
13.8
26
28
C03.9
ICD-10 Finland
Malignant neoplasm: Gum, unspecified
+∞
13.8
13
*
EEB10
NOMESCO Finland
Maxillectomy
+∞
13.8
13
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
13.8
13
*
WX872
NOMESCO Finland
Intensive care
10.1
13.4
27
33
ZZA00
NOMESCO Finland
Split skin graft
22.1
13.4
19
10
GD1AA
NOMESCO Finland
Thorax X-ray examination
4.2
12.9
81
384
K13.20
ICD-10 Finland
Idiopathic leukoplakia
+∞
12.7
12
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
12.7
12
*
JCW98
NOMESCO Finland
Other transluminal endoscopic procedure on oesophagus
+∞
12.7
12
*
EDB20
NOMESCO Finland
Hemimandibulectomy
+∞
12.7
12
*
SXB00
NOMESCO Finland
Removeal of sutres from oral mucosa
11.2
12.7
24
26
Z51.5
ICD-10 Finland
Palliative care
14.6
12.7
21
17
Z2446
NOMESCO Finland
Social worker
10.1
12.5
25
30
A04AA01
ATC
ondansetron; systemic, rectal
17.0
12.3
19
13
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
52.1
12.2
14
*
EKB00
NOMESCO Finland
Excision of lesion of cheek
+∞
11.6
11
*
A04AD12
ATC
aprepitant; systemic
+∞
11.6
11
*
EDC42
NOMESCO Finland
Mandibular repair with implant
+∞
11.6
11
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
11.6
11
*
C06.9
ICD-10 Finland
Malignant neoplasm: Mouth, unspecified
+∞
11.6
11
*
L43.8
ICD-10 Finland
Other lichen planus
28.1
11.4
15
6
SAA01
NOMESCO Finland
Simple examination of mouth
4.2
11.2
99
598
SXA10
NOMESCO Finland
Epithel biopsy of mouth
31.2
11.0
14
5
ZXE20
NOMESCO Finland
More than three and less than five hours
5.7
10.9
33
74
TPH07
NOMESCO Finland
Cathetrisation of artery
6.3
10.8
30
60
K05.31
ICD-10 Finland
Periodontitis pronounced
6.2
10.7
30
61
RS316
NOMESCO Finland
NA
119.7
10.6
11
*
ECA35
NOMESCO Finland
Complicated excision of lesion of gingiva
119.7
10.6
11
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
10.6
10
*
EJB30
NOMESCO Finland
Excision of lesion of floor of mouth
+∞
10.6
10
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
10.6
10
*
C06.0
ICD-10 Finland
Malignant neoplasm: Cheek mucosa
+∞
10.6
10
*
SPA02
NOMESCO Finland
Preparation for dental prosthetics
26.0
10.5
14
6
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
10.6
10.5
20
22
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
11.6
10.5
19
19
Z3226
NOMESCO Finland
Physiotherapist
4.5
10.2
40
118
SXC02
NOMESCO Finland
Other oral or dental procedure, restricted
18.7
10.2
15
9
AA3AI
NOMESCO Finland
Cone beam CT of facial bones
43.9
10.2
12
*
TEA00
NOMESCO Finland
Biopsy of lip
43.9
10.2
12
*
WX402
NOMESCO Finland
General anaesthesia
5.0
9.9
34
87
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
6.6
9.9
26
48
WX730
NOMESCO Finland
Conventional respirator
32.9
9.6
12
*
ECA30
NOMESCO Finland
Excision of lesion of gingiva
32.9
9.6
12
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
107.9
9.6
10
*
EBA00
NOMESCO Finland
Extraction of tooth
3.5
9.5
58
249
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
9.5
9
*
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
9.5
9
*
WZB00
NOMESCO Finland
Telephone receipt or other advice
3.7
9.3
48
179
EB1AI
NOMESCO Finland
Cone beam imaging of teeth and jaws (one quarter)
39.9
9.2
11
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
9.8
9.2
18
21
GD1AD
NOMESCO Finland
Thorax CT examination
10.7
9.1
17
18
SHA03
NOMESCO Finland
Correction of physiology of bite - demanding therapy visit
26.3
9.1
12
5
EBA10
NOMESCO Finland
Surgical removal of tooth
6.4
9.0
24
45
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
3.2
9.0
73
381
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
6.6
9.0
23
41
K05.30
ICD-10 Finland
Periodontitis complex
4.4
8.9
34
97
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
53.9
8.8
10
*
EB1WA
NOMESCO Finland
NA
53.9
8.8
10
*
SPF30
NOMESCO Finland
Soling for prothesis
17.9
8.8
13
8
ZXD10
NOMESCO Finland
Scheduled procedure
3.2
8.7
63
302
B37.08
ICD-10 Finland
Other candidal stomatitis
96.3
8.5
9
*
PH2CD
NOMESCO Finland
Very extensive CT of inferior vena cava, pelvic veins and veins of lower extremity
96.3
8.5
9
*
EJB10
NOMESCO Finland
Excision of lesion of apex or body of tongue
96.3
8.5
9
*
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
96.3
8.5
9
*
SPA05
NOMESCO Finland
Guiding rail
+∞
8.4
8
*
EDC45
NOMESCO Finland
Reconstruction of mandible using bone graft
+∞
8.4
8
*
SPA10
NOMESCO Finland
Setting attachments on tooth or implanted bracket or imblant based structures
+∞
8.4
8
*
C06.29
ICD-10 Finland
Malignant tumor of the retromolar surface UNS
+∞
8.4
8
*
C06.21
ICD-10 Finland
Malignant tumor of the lower retromolar surface
+∞
8.4
8
*
WX707
NOMESCO Finland
Fiberoscopic intubation
+∞
8.4
8
*
SAA02
NOMESCO Finland
Basic examination of mouth
3.1
8.2
85
510
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
3.1
8.1
58
272
R13
ICD-10 Finland
Dysphagia
6.1
7.8
21
40
SPF11
NOMESCO Finland
Fitting of dental prosthesis
48.1
7.8
9
*
SPA48
NOMESCO Finland
Precision impression for denture, demanding
48.1
7.8
9
*
SPF00
NOMESCO Finland
Repatation of teeth prosthesis
8.0
7.8
17
24
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
11.1
7.8
14
14
SPF10
NOMESCO Finland
Demanding repatation of teeth prosthesis
14.6
7.6
12
9
WF049
NOMESCO Finland
Radiotherapy of metastasis
85.0
7.5
8
*
K13.28
ICD-10 Finland
Other leukoplakia or disorder of epithelium of the palate or tongue
85.0
7.5
8
*
TJD20
NOMESCO Finland
Change of gastrostomy tube
85.0
7.5
8
*
K12.10
ICD-10 Finland
Stomatitis NOS
85.0
7.5
8
*
C04.0
ICD-10 Finland
Malignant neoplasm: Anterior floor of mouth
+∞
7.4
7
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
7.4
7
*
EDW99
NOMESCO Finland
Other operation on mandible
+∞
7.4
7
*
ZZQ40
NOMESCO Finland
Free microvascular graft of bone
+∞
7.4
7
*
8070/3-C03.9
ICD-O-3
Squamous cell carcinoma, NOS, of gum, NOS
+∞
7.4
7
*
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
+∞
7.4
7
*
EKC20
NOMESCO Finland
Plastic repair of cheek
+∞
7.4
7
*
QAE30
NOMESCO Finland
Excision and repair of surgical scar in head or neck
+∞
7.4
7
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
+∞
7.4
7
*
K13.74
ICD-10 Finland
Lichen rubs planus in the mouth
32.1
7.3
9
*
SPD00
NOMESCO Finland
Fitting and preparation of total teeth prosthesis
32.1
7.3
9
*
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
10.2
7.0
13
14
WX002
NOMESCO Finland
Sedation and analgesia
3.4
6.9
37
138
ECB20
NOMESCO Finland
Oral alveoplasty
17.9
6.9
10
6
J01CE02
ATC
phenoxymethylpenicillin; oral
2.9
6.8
91
605
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
6.9
6.7
16
26
SXC05
NOMESCO Finland
Other oral or dental procedure
7.3
6.6
15
23
EFB40
NOMESCO Finland
Removal of internal or external fixation device from facial bones
73.5
6.5
7
*
EP2AT
NOMESCO Finland
Neck soft tissue cytology with ultrasound guidance
73.5
6.5
7
*
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
4.6
6.4
22
56
RD210
NOMESCO Finland
NA
19.2
6.4
9
5
ZXA05
NOMESCO Finland
Left side
2.9
6.3
44
197
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
28.3
6.3
8
*
K08.0
ICD-10 Finland
Exfoliation of teeth due to systemic causes
+∞
6.3
6
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
6.3
6
*
EEW99
NOMESCO Finland
Other operation on maxilla
+∞
6.3
6
*
QA4S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in face
+∞
6.3
6
*
EEA10
NOMESCO Finland
Biopsy of maxilla
+∞
6.3
6
*
EHB00
NOMESCO Finland
Excision of lesion of palate
+∞
6.3
6
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
6.3
6
*
PJ5AQ
NOMESCO Finland
Sentinell lymphnode SPECT with low dose CT
+∞
6.3
6
*
L43.0
ICD-10 Finland
Hypertrophic lichen planus
+∞
6.3
6
*
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
+∞
6.3
6
*
L03AA02
ATC
filgrastim; parenteral
+∞
6.3
6
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
7.4
6.2
14
21
SDA02
NOMESCO Finland
Parodonthologic therapy
2.8
6.2
49
236
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
97
67
20.11
113.17
1.7
1.3
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
124
205
9.10
78.32
5.2
6.4
mmol/l
5.3
11.2
15.79
119
191
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
70
8
110.80
65.93
5.9
2.6
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
213
742
6.31
60.36
4.9
1.6
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
46
30
17.66
53.88
2.4
1.2
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
126
309
5.99
52.01
6.9
4.9
mmol/l
0.9
1.0
3.10
126
275
(3002256) Pathology report gross observation
87
160
7.03
48.10
1.7
1.1
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
160
543
4.79
43.63
3.1
1.9
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
38
26
16.39
43.19
1.3
1.2
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
126
357
5.10
43.03
4.5
2.4
mmol/l
0.8
0.8
4.07
126
329
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
96
219
5.78
42.08
1.8
1.8
%
1.9
1.6
1.50
90
185
(3044640) Blood type and Crossmatch panel - Blood
178
703
4.34
38.62
3.6
2.0
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
220
1062
4.23
34.84
4.9
3.6
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
215
1103
3.74
29.27
5.0
3.6
g/l
34.7
35.4
0.95
210
1004
(3007853) Bacteria identified in Skin by Aerobe culture
92
292
3.99
25.64
2.0
1.7
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
106
382
3.62
24.38
2.3
1.8
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
168
848
3.00
21.39
4.4
2.1
mmol/l
2.4
2.4
1.36
157
694
(3000494) Fungus identified in Specimen by Culture
87
299
3.60
21.22
2.5
1.4
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
192
1081
2.86
19.35
6.7
9.5
inr
1.1
1.3
6.72
31
296
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
35
65
5.91
18.50
2.1
2.2
mg/l
1.1
1.5
4.25
35
60
(3023368) Bacteria identified in Blood by Culture
137
675
2.76
17.43
4.3
3.8
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
118
551
2.78
16.51
1.4
1.3
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
46
122
4.22
16.01
15.8
7.9
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
49
137
4.03
15.88
11.4
5.6
mmol/l
25.6
25.7
0.06
49
137
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
192
1161
2.57
15.57
9.0
4.9
mmol/l
1.2
1.2
1.94
182
1021
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
70
255
3.22
15.19
2.2
3.5
ng/l
166.0
247.3
0.80
64
239
(3035637) Corticotropin [Mass/volume] in Plasma
17
17
10.49
15.04
1.2
1.4
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
67
246
3.16
14.30
16.3
6.0
g/l
112.0
123.7
4.81
67
240
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
199
1271
2.43
13.65
9.3
5.4
mmol/l
1.2
1.2
1.13
171
1086
(3013826) Glucose [Moles/volume] in Serum or Plasma
227
1543
2.52
13.49
9.9
4.0
mmol/l
6.6
6.8
1.32
219
1432
(3013650) Neutrophils [#/volume] in Blood by Automated count
202
1316
2.39
13.00
10.3
6.0
e9/l
4.3
4.4
0.36
180
1137
(3016502) Oxygen saturation in Arterial blood
67
270
2.86
12.02
16.4
5.6
%
97.4
95.1
3.71
67
263
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
167
1035
2.25
11.67
2.4
2.3
nmol/l
78.4
78.6
0.03
155
893
(3003396) Base excess in Arterial blood by calculation
71
300
2.74
11.62
15.7
5.6
mmol/l
1.4
1.6
0.29
66
242
(42870588) Differential panel, method unspecified - Blood
133
770
2.22
10.79
6.0
5.3
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
84
401
2.47
10.65
1.7
1.8
—
—
—
0
0
(3000991) Gas panel - Venous blood
55
213
2.90
10.55
16.7
5.8
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
63
264
2.71
10.42
2.1
2.4
umol/l
9.1
8.4
0.06
55
228
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
250
1896
2.33
9.82
8.9
5.4
u/l
82.2
76.0
1.36
240
1720
(40758558) Short blood count panel - Blood
103
556
2.24
9.76
8.2
4.5
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
71
327
2.49
9.65
12.9
4.6
mmol/l
103.8
104.0
0.08
71
317
(3018418) pH of Serum or Plasma
123
760
1.99
7.88
3.9
3.2
ph
7.4
7.4
1.39
19
113
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
61
293
2.33
7.45
1.7
1.7
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
38
145
2.83
7.43
1.5
1.7
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
206
1536
1.91
7.31
3.1
3.0
u/l
48.6
47.6
0.05
198
1414
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
94
555
1.97
6.70
3.9
4.0
ng/l
198.9
284.8
0.27
85
464
(3019198) Lymphocytes [#/volume] in Blood
169
1205
1.83
6.69
6.0
5.1
e9/l
1.8
1.8
0.01
147
1047
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
40
166
2.60
6.66
1.6
1.6
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
171
1225
1.82
6.65
6.3
5.2
e9/l
0.2
0.2
0.04
154
1066
(3022096) Basophils/100 leukocytes in Blood
152
1055
1.82
6.52
6.4
5.2
%
0.7
0.7
0.01
143
967
(3006504) Eosinophils/100 leukocytes in Blood
156
1092
1.82
6.50
6.3
5.2
%
2.9
3.0
0.10
146
996
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
49
228
2.35
6.40
2.5
2.0
u/l
35.6
32.4
0.21
39
179
(3019069) Monocytes/100 leukocytes in Blood
156
1097
1.80
6.37
6.7
5.5
%
8.9
8.7
0.37
147
1008
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
58
291
2.21
6.35
1.7
1.8
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
158
1118
1.80
6.29
6.4
5.3
%
24.3
26.7
1.59
146
1022
(3000492) Spirometry study
45
204
2.40
6.23
1.4
1.4
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
164
1178
1.78
6.17
6.0
5.0
e9/l
0.6
0.6
0.25
141
1006
(3006315) Basophils [#/volume] in Blood
165
1189
1.78
6.13
6.0
5.0
e9/l
0.0
0.0
0.19
143
1016
(3018010) Neutrophils/100 leukocytes in Blood
156
1113
1.76
5.94
6.2
5.1
%
60.7
58.1
1.56
145
1020
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
33
134
2.63
5.74
3.0
1.4
ug/l
3.7
5.0
0.23
25
103
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
22
71
3.25
5.73
2.8
2.5
u/ml
0.2
0.3
3.10
14
39
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
134
926
1.75
5.62
2.9
3.0
ng/l
1010.9
1592.9
1.52
118
789
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
8
5
16.34
5.43
5.0
1.0
u/ml
18.1
14.2
—
8
5
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
8
8
10.21
4.54
1.0
1.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
27
113
2.51
4.44
1.6
1.3
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
10
22
4.66
4.33
1.5
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
164
1261
1.60
4.23
2.5
2.5
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
142
1064
1.59
4.03
10.1
8.2
e9/l
0.0
0.0
0.06
115
859
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
9
15
6.13
3.84
1.6
1.3
ug/l
13.2
15.7
—
9
15
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
65
405
1.75
3.74
2.8
2.8
e6/l
3.0
2.9
0.02
34
208
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
15
50
3.10
3.74
1.1
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
15
50
3.10
3.74
1.1
1.2
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
279
2498
1.77
3.44
26.7
13.6
mg/l
40.9
24.0
6.87
257
1941
(1761868) Lipid panel - Serum or Plasma
51
797
0.57
3.32
2.3
3.3
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
38
208
1.93
3.30
2.9
2.1
ml/min/173m2
69.5
59.7
1.10
18
80
(3020682) Albumin/Creatinine [Ratio] in Urine
66
954
0.61
3.13
3.4
3.9
mg/mmol
3.8
8.0
1.55
36
595
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
76
520
1.60
3.05
4.1
2.2
mmol/l
2.5
2.4
1.12
64
436
(3013707) Erythrocyte sedimentation rate by Westergren method
223
1920
1.50
2.95
4.3
4.2
mm/h
16.2
13.1
1.90
210
1730
(40768806) Pleura Pathology biopsy report
8
17
4.79
2.93
1.5
1.3
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
16
64
2.58
2.92
1.4
1.5
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
7
13
5.48
2.88
1.3
4.4
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
93
677
1.52
2.83
3.1
2.8
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
7
14
5.08
2.74
1.3
1.1
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
14
54
2.66
2.74
2.3
2.1
%
91.5
89.6
0.15
14
49
(3002582) Erythrocytes [#/volume] in Urine
102
766
1.48
2.65
3.2
2.9
e6/l
40.1
133.5
0.55
82
578
(3018095) Leukocytes [#/volume] in Urine
116
895
1.46
2.63
3.8
3.5
e6/l
73.9
111.4
0.48
82
633
(3012516) Albumin [Mass/volume] in Urine
64
901
0.64
2.62
2.9
3.2
mg/l
30.2
323.1
1.55
41
568
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
230
2545
0.68
2.54
4.3
4.8
mmol/l
4.6
4.5
0.32
210
2318
(3044889) 12 lead EKG panel
214
1857
1.44
2.50
4.7
4.1
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
116
903
1.44
2.48
3.1
3.0
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
23
118
2.02
2.42
1.3
1.3
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
228
2520
0.69
2.41
4.1
4.8
mmol/l
1.5
1.5
0.32
198
2289
(3026782) Osmolality of Urine
71
504
1.52
2.40
2.5
2.6
mosm/kgh2o
496.8
546.0
1.22
63
405
(3036481) Cortisol [Moles/volume] in Serum or Plasma
39
240
1.71
2.36
4.4
1.7
nmol/l
467.1
373.7
2.13
39
213
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
17
78
2.24
2.35
1.7
1.6
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
42
264
1.68
2.35
4.1
3.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
25
134
1.94
2.34
1.1
1.2
iu/ml
112.5
121.5
—
7
41
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
18
85
2.18
2.33
1.7
1.6
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
94
711
1.45
2.33
3.1
2.9
e6/l
0.4
0.5
0.38
74
522
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
63
441
1.53
2.27
2.5
2.5
e6/l
1.3
1.3
0.01
32
243
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
74
984
0.68
2.23
3.7
4.0
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
13
54
2.47
2.22
1.1
1.1
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
68
915
0.68
2.18
2.8
3.1
mmol/l
6.9
7.3
0.35
57
767
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
41
614
0.62
2.17
1.7
1.8
pmol/l
518.0
442.4
0.73
35
507
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
35
214
1.71
2.17
1.3
1.4
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
7
19
3.74
2.16
1.6
1.2
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
6
14
4.34
2.16
1.3
1.2
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
59
413
1.52
2.13
21.7
26.7
inr
1.0
1.3
—
6
56
(3031040) Bacteria [#/volume] in Urine by Automated count
193
1670
1.38
2.13
4.3
4.5
—
7133.5
—
0
23
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
73
536
1.47
2.09
1.7
1.6
mg/l
1.2
1.2
0.01
55
410
(3002385) Erythrocyte distribution width [Ratio]
228
2033
1.40
2.06
31.2
15.9
%
14.0
13.7
2.04
221
1982
(3024928) Oxygen saturation in Venous blood
14
63
2.28
2.04
1.3
2.3
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
48
681
0.65
1.98
2.9
3.4
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
11
45
2.49
1.95
1.3
1.3
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
18
94
1.97
1.84
1.2
1.7
ug/l
6.5
2.0
0.30
13
82
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
5
12
4.21
1.83
1.0
1.0
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
71
532
1.43
1.83
2.4
2.3
e6/l
7.6
7.1
0.07
65
450
(46235355) HIV 1 and 2 tests - Meaningful Use set
38
250
1.59
1.81
1.4
1.6
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
7
23
3.09
1.81
1.1
1.3
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
13
60
2.21
1.80
1.3
1.5
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
12
54
2.27
1.76
1.3
1.7
%
50.0
62.2
0.89
12
54
(3047181) Lactate [Moles/volume] in Blood
15
75
2.05
1.72
14.1
6.4
mmol/l
0.8
1.5
3.31
15
70
(3019060) Gas panel - Arterial blood
28
174
1.67
1.67
8.8
4.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
14
69
2.07
1.67
2.4
3.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
30
190
1.64
1.67
1.5
1.4
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
46
327
1.47
1.56
1.9
2.4
%
17.9
23.2
1.48
39
285
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
244
2615
0.74
1.54
4.7
5.4
mmol/l
2.7
2.6
0.38
214
2375
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
33
219
1.56
1.53
1.8
3.9
ng/l
50.8
85.0
4.40
28
195
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
5
15
3.37
1.53
1.2
1.7
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
5
15
3.37
1.53
1.2
1.7
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
15
79
1.94
1.52
1.3
1.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
11
52
2.15
1.46
1.4
1.2
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
31
452
0.65
1.46
1.3
1.3
iu/ml
52.7
39.1
—
8
151
(42529406) Shigella sp [Presence] in Stool by Culture
15
81
1.89
1.42
1.3
1.2
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
140
1204
1.28
1.42
2.2
2.0
pmol/l
96.3
95.2
0.09
65
600
(3019550) Sodium [Moles/volume] in Serum or Plasma
284
2685
1.42
1.39
30.7
16.5
mmol/l
138.8
139.7
4.50
277
2601
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
6
23
2.64
1.37
1.2
1.0
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
278
2621
1.39
1.36
22.2
13.1
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
284
2688
1.41
1.35
30.7
16.7
mmol/l
4.0
4.0
1.79
278
2604
(3026008) Bacteria identified in Urine by Culture
101
839
1.29
1.33
2.9
3.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
16
91
1.80
1.31
1.5
1.9
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
6
24
2.53
1.31
1.2
1.0
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
6
24
2.53
1.31
1.2
1.0
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
6
24
2.53
1.31
1.2
1.0
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
6
24
2.53
1.31
1.2
1.0
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
6
24
2.53
1.31
1.2
1.0
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
8
34
2.39
1.30
1.1
1.0
—
—
—
0
0
(40768793) Breast Pathology biopsy report
5
18
2.80
1.29
1.2
1.1
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
6
26
2.33
1.19
1.3
3.7
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
14
79
1.81
1.19
1.4
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
10
50
2.03
1.17
1.5
1.2
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
0
33
0.00
1.17
0.0
2.5
—
575.7
—
0
23
(3016879) Cocaine [Presence] in Urine
8
39
2.08
1.16
1.3
1.2
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
8
39
2.08
1.16
1.3
1.2
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
14
80
1.78
1.14
1.1
1.0
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
256
2404
1.29
1.14
24.2
12.2
ml/min/173m2
81.9
74.9
7.69
230
1903
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
7
30
2.36
1.13
1.3
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
7
30
2.36
1.13
1.1
1.1
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
24
160
1.54
1.13
1.5
1.4
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
25
360
0.67
1.13
4.5
5.1
%
33.0
32.2
0.12
17
231
(3016650) Hepatitis A virus Ab [Presence] in Serum
8
40
2.02
1.13
1.1
1.1
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
7
31
2.28
1.11
1.0
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
17
265
0.62
1.10
1.6
1.6
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
8
41
1.97
1.09
1.3
1.2
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
8
41
1.97
1.09
1.3
1.2
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
5
21
2.40
1.09
3.0
3.1
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
9
46
1.98
1.04
1.2
1.2
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
9
47
1.94
1.03
1.6
1.6
mu/l
608.9
278.1
—
9
42
(3004716) Salmonella sp identified in Stool by Organism specific culture
17
107
1.62
1.02
1.4
1.3
—
—
—
0
0
(3019225) pH of Specimen
34
250
1.40
1.01
2.6
3.9
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
229
2434
0.81
1.01
3.7
4.3
mmol/l
1.3
1.3
0.18
204
2183
(3022948) Iron [Moles/volume] in Serum or Plasma
50
393
1.32
0.98
1.9
2.3
umol/l
9.9
12.9
2.30
50
356
(3008152) Bicarbonate [Moles/volume] in Arterial blood
25
174
1.47
0.98
11.5
5.8
mmol/l
25.9
24.9
0.86
25
165
(4062490)
5
23
2.19
0.98
1.4
1.3
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
20
134
1.52
0.94
2.3
3.2
mmol/l
26.7
24.7
2.02
20
119
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
39
299
1.35
0.91
1.3
1.4
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
6
30
2.02
0.87
1.2
1.6
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
32
419
0.74
0.86
1.3
1.3
u/ml
39.0
12.7
0.58
15
162
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
31
1.95
0.85
1.0
1.1
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
6
32
1.89
0.82
1.2
1.2
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
207
1933
1.19
0.80
4.5
3.7
pmol/l
14.9
15.0
0.25
192
1728
(3016750) Collection duration of Urine
0
24
0.00
0.79
0.0
2.5
—
485.2
—
0
18
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
8
48
1.68
0.79
1.1
1.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
8
48
1.68
0.79
1.0
1.5
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
27
0.00
0.78
0.0
1.0
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
0
27
0.00
0.78
0.0
1.0
—
—
—
0
0
(40768443) Skin Pathology biopsy report
15
99
1.54
0.77
1.3
1.2
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
6
34
1.78
0.76
1.3
1.4
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
70
594
1.23
0.76
1.9
1.8
nmol/l
1049.4
1215.4
0.60
52
455
(40760888) Immunoglobulin light chains.free panel - Serum
9
55
1.65
0.74
1.2
1.4
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
7
38
1.86
0.74
1.1
1.2
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
5
25
2.01
0.73
1.2
1.2
—
—
—
0
0
(4010399)
27
204
1.35
0.71
1.2
1.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
236
2241
1.19
0.70
30.9
14.6
%
36.8
39.7
5.52
170
1452
(3027008) Opiates [Presence] in Urine
7
41
1.72
0.70
1.3
1.2
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
77
666
1.20
0.70
2.4
2.2
mg/l
2.3
3.1
2.89
66
562
(3048929) Epstein Barr virus Ab [Presence] in Serum
7
43
1.64
0.67
1.1
1.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
13
86
1.53
0.67
1.6
3.9
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
10
152
0.65
0.62
1.6
1.9
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
10
63
1.61
0.62
1.4
1.3
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
16
113
1.44
0.62
3.4
2.6
pmol/l
4.3
4.4
0.11
16
97
(21494755) Public health laboratory ask at order entry panel
9
137
0.65
0.62
1.3
1.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
8
50
1.61
0.61
1.1
1.2
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
8
50
1.61
0.61
1.1
1.1
u/l
11.5
17.1
—
8
44
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
5
30
1.68
0.61
1.0
1.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
5
30
1.68
0.61
1.0
1.2
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
5
30
1.68
0.61
1.0
1.2
u/ml
358.8
273.0
—
5
16
(4024509)
0
20
0.00
0.60
0.0
1.4
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
21
0.00
0.60
0.0
1.6
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
1.2
—
178.8
—
0
21
(3000034) Microalbumin [Mass/volume] in Urine
0
22
0.00
0.59
0.0
3.4
—
21.0
—
0
17
(3029937) Albumin [Presence] in Urine by Test strip
58
672
0.83
0.59
3.7
4.1
estimate
0.0
0.0
0.50
21
194
(3019150) Specific gravity of Urine by Refractometry
51
597
0.83
0.58
3.9
4.1
kg/l
1.0
1.0
—
9
94
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
61
702
0.84
0.58
1.8
1.7
mmol/l
1.3
1.3
0.01
53
579
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
6
36
1.68
0.57
1.3
1.5
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
5
88
0.56
0.57
1.8
4.6
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
187
1762
1.14
0.55
4.3
4.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
38
1.59
0.54
1.0
1.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
247
2560
0.86
0.54
4.5
5.0
mmol/l
5.8
6.1
3.54
223
2299
(3020564) Creatinine [Moles/volume] in Serum or Plasma
279
2709
1.20
0.53
30.5
15.8
umol/l
73.8
80.7
5.37
279
2709
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
9
133
0.67
0.53
1.9
1.8
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
12
84
1.44
0.50
1.1
1.2
—
0.2
—
0
7
(3044290) Cell count panel - Cerebral spinal fluid
7
45
1.57
0.49
1.1
1.0
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
5
81
0.61
0.46
1.2
1.7
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
29
238
1.24
0.46
1.8
2.6
e9/l
68.1
70.1
0.07
20
193
(3017732) Neutrophils [#/volume] in Blood
22
175
1.28
0.44
1.3
2.8
e9/l
4.2
4.1
0.07
17
117
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
89
810
1.14
0.44
3.4
2.2
u/l
48.0
57.3
1.96
82
740
(3022145) Colonoscopy Study observation
27
221
1.24
0.44
1.1
1.3
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
278
2710
1.17
0.43
12.6
9.2
u/l
22.9
24.9
1.65
267
2579
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
5
32
1.57
0.42
1.0
1.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
8
58
1.39
0.42
1.9
2.1
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
286
2796
1.18
0.41
35.5
19.7
e9/l
253.3
244.4
1.28
274
2711
(3024731) MCV [Entitic volume]
286
2796
1.18
0.41
35.5
19.7
fl
92.0
91.4
1.31
280
2739
(3014148) Varicella zoster virus Ab [Titer] in Serum
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(44813793)
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
16
0.00
0.41
0.0
1.3
—
7.4
—
0
16
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
0
17
0.00
0.41
0.0
1.1
—
3.9
—
0
9
(3008401) Mugwort IgE Ab [Units/volume] in Serum
0
17
0.00
0.41
0.0
1.1
—
1.0
—
0
9
(3000012) Reticulocyte production index
0
17
0.00
0.41
0.0
2.2
—
—
—
0
0
(3035941) MCH [Entitic mass]
286
2797
1.17
0.40
35.4
19.6
pg
30.5
30.4
0.31
280
2740
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.4
—
1.0
—
0
18
(3000963) Hemoglobin [Mass/volume] in Blood
286
2798
1.17
0.39
35.7
19.8
g/l
124.7
135.5
20.08
280
2739
(3026361) Erythrocytes [#/volume] in Blood
286
2798
1.17
0.39
35.6
19.7
e12/l
4.1
4.5
16.92
271
2698
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
0
19
0.00
0.39
0.0
1.1
—
1.1
—
0
12
(4027681)
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
286
2799
1.17
0.39
35.6
19.7
e9/l
7.2
6.7
1.54
273
2701
(3021440) Promyelocytes/100 leukocytes in Blood
20
161
1.26
0.38
3.7
4.1
%
0.0
0.1
—
5
34
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
8
115
0.69
0.37
1.5
1.7
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
91
983
0.90
0.36
4.6
3.8
ug/l
1.7
2.0
0.66
70
868
(3021960) Folate [Moles/volume] in Serum or Plasma
77
706
1.12
0.34
1.6
1.5
nmol/l
19.7
21.4
0.42
68
599
(3011397) Hemoglobin [Presence] in Urine by Test strip
66
601
1.12
0.33
3.4
3.8
—
—
—
0
0
(3012544) pH of Venous blood
24
284
0.83
0.33
2.2
3.0
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
72
783
0.90
0.32
4.2
3.6
%
21.7
24.9
0.72
23
362
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
31
354
0.86
0.29
7.0
7.6
—
—
—
0
0
(3013512) EKG study
80
859
0.91
0.28
4.7
4.2
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
10
76
1.33
0.28
1.3
1.4
—
1.1
—
0
11
(4094501)
5
71
0.70
0.26
1.2
1.1
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
119
1247
0.93
0.24
3.1
3.8
estimate
0.0
0.0
0.00
20
199
(3000330) Specific gravity of Urine by Test strip
12
147
0.81
0.24
1.9
3.8
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
14
168
0.83
0.23
1.0
1.4
—
51.4
—
0
10
(3017181) Myelocytes/100 leukocytes in Blood
20
172
1.17
0.22
3.7
4.0
%
0.0
0.6
—
5
40
(3005322) IgE [Units/volume] in Serum or Plasma
11
135
0.81
0.22
1.7
1.2
u/ml
95.7
256.5
1.74
11
119
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
5
41
1.22
0.22
2.4
1.3
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40768441) Liver Pathology biopsy report
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
8
102
0.78
0.21
1.0
1.5
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
8
102
0.78
0.21
2.1
1.6
—
163.3
—
0
6
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
53
491
1.09
0.21
1.2
1.2
u/ml
0.7
1.5
0.98
13
114
(3023511) Choriogonadotropin [Units/volume] in Urine
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
2.2
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
6
49
1.23
0.20
1.2
1.4
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
6
50
1.20
0.20
1.0
1.3
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
7
59
1.19
0.18
1.9
3.0
kpa
7.3
8.2
—
7
59
(3013290) Carbon dioxide [Partial pressure] in Blood
7
59
1.19
0.18
1.9
3.0
kpa
4.7
5.2
—
7
59
(3048689) Calprotectin [Mass/mass] in Stool
27
245
1.11
0.16
1.3
2.2
ug/g
343.9
144.5
0.36
22
190
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
6
78
0.77
0.15
1.2
1.3
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
18
203
0.88
0.15
3.0
3.5
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
121
1250
0.95
0.15
4.4
5.2
estimate
0.0
0.0
0.00
21
195
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
7
89
0.78
0.14
1.3
1.9
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
123
1268
0.95
0.14
3.2
3.8
estimate
0.0
0.0
0.00
21
193
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
240
2366
1.05
0.13
5.8
4.6
mu/l
2.4
2.0
0.98
217
2122
(3020891) Body temperature
9
107
0.84
0.13
5.1
3.5
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
14
158
0.88
0.12
1.0
1.3
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
24
220
1.10
0.12
2.1
2.5
kpa
4.7
4.3
0.26
24
210
(3021901) Oxygen saturation in Capillary blood
5
45
1.11
0.10
2.8
1.8
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
5
62
0.80
0.08
1.2
1.3
e6/l
227.0
153.3
—
5
53
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
5
62
0.80
0.08
1.2
1.1
e6/l
5.4
2.7
—
5
52
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
14
154
0.91
0.08
2.8
2.5
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
7
65
1.08
0.08
1.3
1.8
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
6
73
0.82
0.07
1.0
1.2
—
2.6
—
0
11
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
6
74
0.81
0.07
1.0
1.2
—
4.4
—
0
11
(3007164) IgA [Mass/volume] in Serum or Plasma
41
428
0.95
0.07
1.3
1.3
g/l
2.3
2.7
0.67
21
239
(3037522) Nuclear Ab [Titer] in Serum
31
326
0.95
0.07
1.3
1.3
titre
288.0
497.0
—
5
92
(40760892) CBC W Ordered Manual Differential panel - Blood
51
492
1.04
0.07
3.7
4.2
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
9
84
1.07
0.07
4.3
3.4
mmol/l
3.8
3.9
—
9
79
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
9
100
0.90
0.06
1.1
1.0
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
26
271
0.96
0.04
2.3
3.0
kpa
6.7
5.9
1.88
26
263
(3022621) pH of Urine by Test strip
19
180
1.06
0.04
2.2
2.8
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
19
180
1.06
0.04
1.2
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
10
92
1.09
0.03
1.8
1.8
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
247
2458
1.02
0.03
5.3
6.5
mmol/mol
38.3
40.8
5.90
234
2259
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
11
102
1.08
0.03
1.4
1.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
13
137
0.95
0.01
3.3
4.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
54
547
0.98
0.01
2.5
2.6
ug/l
0.7
0.7
0.17
30
368
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
110
1107
0.99
0.01
3.9
4.0
ng/l
20.2
69.7
1.04
76
828
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
27
268
1.01
0.00
1.3
1.4
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
35
351
1.00
0.00
1.5
1.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
23
227
1.01
0.00
3.5
3.2
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
19
186
1.02
0.00
1.7
1.4
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
7
73
0.96
0.00
2.4
1.8
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
7
0.00
0.00
0.0
6.1
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
6
0.00
0.00
0.0
2.3
—
1.3
—
0
6
(3016330) Potassium [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
7
0.00
0.00
0.0
6.3
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
7
0.00
0.00
0.0
4.7
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019174) dRVVT (LA screen)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
11
110
1.00
0.00
2.1
1.3
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
5
56
0.89
0.00
3.8
4.1
mg/l
19.8
23.6
—
5
36
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
7
0.00
0.00
0.0
3.3
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
104
1040
1.00
0.00
2.6
2.6
ug/l
113.1
130.2
0.61
96
943
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
0.5
—
0
6
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.2
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
1410.6
—
0
8
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
72.0
—
0
5
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
7
0.00
0.00
0.0
3.3
—
—
—
0
0
(1616796) Gas panel - Central venous blood
5
49
1.02
0.00
2.2
2.8
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(4133840)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
6
0.00
0.00
0.0
6.8
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
5
0.00
0.00
0.0
2.2
—
7.2
—
0
5
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_GUM_EXALLC – Malignant neoplasm of gum, excluding all cancers (controls excluding all cancers)
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).